Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytoma, Benign Fibrous | 1 | 2022 | 73 | 0.850 |
Why?
|
| Exanthema | 1 | 2022 | 211 | 0.730 |
Why?
|
| Down Syndrome | 1 | 2022 | 226 | 0.710 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 308 | 0.660 |
Why?
|
| Psoriasis | 3 | 2006 | 126 | 0.390 |
Why?
|
| Urticaria | 2 | 2006 | 23 | 0.340 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 4654 | 0.310 |
Why?
|
| Nocardia asteroides | 1 | 2006 | 4 | 0.300 |
Why?
|
| Nocardia Infections | 1 | 2006 | 34 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2006 | 1538 | 0.290 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2006 | 44 | 0.290 |
Why?
|
| Brain Abscess | 1 | 2006 | 60 | 0.280 |
Why?
|
| Immunocompromised Host | 2 | 2022 | 698 | 0.250 |
Why?
|
| Anti-Infective Agents | 2 | 2022 | 446 | 0.210 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2022 | 418 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2022 | 994 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 4 | 2006 | 4367 | 0.190 |
Why?
|
| Bacteria | 2 | 2022 | 611 | 0.190 |
Why?
|
| Candida | 1 | 2022 | 164 | 0.190 |
Why?
|
| Lichenoid Eruptions | 1 | 2019 | 36 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2022 | 479 | 0.160 |
Why?
|
| Drug Eruptions | 1 | 2019 | 256 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2022 | 834 | 0.140 |
Why?
|
| Monocytes | 1 | 2019 | 788 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 677 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 2992 | 0.110 |
Why?
|
| Hand Dermatoses | 1 | 2011 | 25 | 0.100 |
Why?
|
| Granuloma Annulare | 1 | 2011 | 9 | 0.100 |
Why?
|
| Adalimumab | 2 | 2006 | 38 | 0.090 |
Why?
|
| Neurofibromatoses | 1 | 2006 | 17 | 0.070 |
Why?
|
| Acitretin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2006 | 72 | 0.070 |
Why?
|
| Pityriasis Rubra Pilaris | 1 | 2006 | 5 | 0.070 |
Why?
|
| Keratolytic Agents | 1 | 2006 | 20 | 0.070 |
Why?
|
| Humans | 17 | 2022 | 261506 | 0.070 |
Why?
|
| Nevus | 1 | 2006 | 107 | 0.070 |
Why?
|
| Paresthesia | 1 | 2005 | 33 | 0.070 |
Why?
|
| Malus | 1 | 2005 | 9 | 0.070 |
Why?
|
| Dermatologic Agents | 1 | 2006 | 53 | 0.070 |
Why?
|
| Mouth Diseases | 1 | 2005 | 34 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 58 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 184 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2006 | 2819 | 0.060 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 33 | 0.060 |
Why?
|
| Melanoma | 3 | 2006 | 5317 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2006 | 349 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 461 | 0.050 |
Why?
|
| Chickenpox | 1 | 2002 | 31 | 0.050 |
Why?
|
| Herpesvirus 3, Human | 1 | 2002 | 43 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 39 | 0.050 |
Why?
|
| Herpes Zoster | 1 | 2002 | 50 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 1021 | 0.050 |
Why?
|
| Drug Resistance, Fungal | 1 | 2022 | 92 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 755 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 1375 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2019 | 86 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2019 | 102 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 223 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2006 | 739 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 960 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2006 | 3251 | 0.040 |
Why?
|
| Antiviral Agents | 2 | 2022 | 1230 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 4844 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 14289 | 0.030 |
Why?
|
| Infliximab | 2 | 2006 | 130 | 0.030 |
Why?
|
| Female | 6 | 2019 | 141928 | 0.030 |
Why?
|
| Amlodipine | 1 | 2011 | 22 | 0.030 |
Why?
|
| Sotalol | 1 | 2011 | 31 | 0.020 |
Why?
|
| Polypharmacy | 1 | 2011 | 57 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 8873 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 86204 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 77950 | 0.020 |
Why?
|
| Male | 7 | 2019 | 123000 | 0.020 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2005 | 4 | 0.020 |
Why?
|
| Cetirizine | 1 | 2005 | 5 | 0.020 |
Why?
|
| Etanercept | 1 | 2005 | 54 | 0.020 |
Why?
|
| Apraxias | 1 | 2005 | 12 | 0.020 |
Why?
|
| Gene Library | 1 | 2006 | 294 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2006 | 587 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 2352 | 0.020 |
Why?
|
| Aged | 3 | 2019 | 70117 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 869 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2005 | 135 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 793 | 0.010 |
Why?
|
| Chickenpox Vaccine | 1 | 2002 | 18 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2005 | 1391 | 0.010 |
Why?
|
| Decision Trees | 1 | 2002 | 178 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 2489 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 2314 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 2944 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 3569 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 2450 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 1547 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 4307 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 37905 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 7548 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 6295 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 6150 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 5112 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 6682 | 0.010 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 14551 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 31252 | 0.000 |
Why?
|
| Child | 1 | 2005 | 29154 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 34495 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 59536 | 0.000 |
Why?
|